Bausch+Lomb Results Presentation Deck

Three Key Takeaways D Growing Revenue At or Above Market +8% CC¹ revenue growth vs 3Q22 Preparing for one of most active launch years in company history Building Selling Excellence Leading in dry eye disease Strong early Miebo™M performance, unlocking full Xiidra® potential BAUSCH+ LOMB 1. Constant currency. This is a non-GAAP measure or ratio. See Slide 1 and Appendix for further information on non-GAAP measures and ratios. 11!! Improving Supply Chain Expect optimized order processing at Lynchburg facility in Q1 2024 Leadership team in place to strengthen supply chain 3

View entire presentation